Immunohistochemical study of alpha 1-5 chains of type IV collagen in hereditary nephritis
- PMID: 7853802
- DOI: 10.1038/ki.1994.413
Immunohistochemical study of alpha 1-5 chains of type IV collagen in hereditary nephritis
Abstract
The distribution of alpha 1-5 chains of type IV collagen [alpha 1-5(IV)] in the glomerular basement membrane (GBM) and epidermal basement membrane (EBM) of 23 families with hereditary nephritis was examined by indirect immunofluorescence. These families were divided into three clinicopathological groups. Group I (10 families) patients showed a widespread "basket weave" pattern of the GBM and a family history of nephritis was present. Group II (6 families) patients showed a widespread "basket weave" change without a family history of nephritis. Group III (7 families) patients showed a widespread attenuation of the GBM but no "basket weave" change, and had a family history of nephritis and chronic renal failure. alpha 1(IV) and alpha 2(IV) were present in all affected and unaffected family members and controls. All normal family members and controls expressed alpha 3(IV), alpha 4(IV) and alpha 5(IV) in the GBM and alpha 5(IV) in the EBM in a diffuse pattern. All group I families and three of the group II families exhibited complete loss of the alpha 5(IV) antigen from the GBM and EBM in male patients, and segmental loss of the alpha 5(IV) antigen in female patients. In these families the alpha 3(IV) and alpha 4(IV) antigens were completely lost from the GBM in male patients with severe nephritis, whereas alpha 3(IV) alpha 4(IV) were present but diminished in male patients with mild nephritis. Three group II and all group III families expressed the alpha 3-5(IV) antigens in an identical manner to that of normal controls. These findings indicate that the heterogeneity of hereditary nephritis reflects a variety of aberrant expression patterns of alpha 3-5(IV) and that immunohistochemical examination of alpha 5(IV) in the EBM is a useful method for the diagnosis of X-linked Alport syndrome.
Similar articles
-
Distribution of alpha-chains of type IV collagen in glomerular basement membranes with ultrastructural alterations suggestive of Alport syndrome.Nephrol Dial Transplant. 2001 May;16(5):945-52. doi: 10.1093/ndt/16.5.945. Nephrol Dial Transplant. 2001. PMID: 11328899
-
Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution.Kidney Int. 1995 Apr;47(4):1142-7. doi: 10.1038/ki.1995.163. Kidney Int. 1995. PMID: 7783412
-
A clinicopathological study of Alport syndrome and detection of type IV collagen chains in Alport patients.Chin Med J (Engl). 1998 Sep;111(9):797-802. Chin Med J (Engl). 1998. PMID: 11155669
-
[Molecular genetics of Alport syndrome].Nihon Rinsho. 1992 Dec;50(12):3021-6. Nihon Rinsho. 1992. PMID: 1491454 Review. Japanese.
-
Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes.Medicine (Baltimore). 1999 Sep;78(5):338-60. doi: 10.1097/00005792-199909000-00005. Medicine (Baltimore). 1999. PMID: 10499074 Review.
Cited by
-
How to resolve confusion in the clinical setting for the diagnosis of heterozygous COL4A3 or COL4A4 gene variants? Discussion and suggestions from nephrologists.Clin Exp Nephrol. 2020 Aug;24(8):651-656. doi: 10.1007/s10157-020-01880-1. Epub 2020 Mar 30. Clin Exp Nephrol. 2020. PMID: 32232700 Free PMC article. Review.
-
Transfer of the alpha 5(IV) collagen chain gene to smooth muscle restores in vivo expression of the alpha 6(IV) collagen chain in a canine model of Alport syndrome.Am J Pathol. 2003 Mar;162(3):873-85. doi: 10.1016/s0002-9440(10)63883-7. Am J Pathol. 2003. PMID: 12598321 Free PMC article.
-
Determination of the pathogenicity of known COL4A5 intronic variants by in vitro splicing assay.Sci Rep. 2019 Sep 3;9(1):12696. doi: 10.1038/s41598-019-48990-9. Sci Rep. 2019. PMID: 31481700 Free PMC article.
-
Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis.J Clin Invest. 1997 May 15;99(10):2470-8. doi: 10.1172/JCI119431. J Clin Invest. 1997. PMID: 9153291 Free PMC article.
-
Negative Staining for COL4A5 Correlates With Worse Prognosis and More Severe Ultrastructural Alterations in Males With Alport Syndrome.Kidney Int Rep. 2016 Sep 29;2(1):44-52. doi: 10.1016/j.ekir.2016.09.056. eCollection 2017 Jan. Kidney Int Rep. 2016. PMID: 29142939 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources